awmsg logo



c1-esterase inhibitor (Berinert®)


Reference No. 2315

Publication date:
17/05/2018


Appraisal information

c1-esterase inhibitor (Berinert®) 2000 IU powder and solvent for solution for injection
c1-esterase inhibitor (Berinert®) 3000 IU powder and solvent for solution for injection


Company: CSL Behring UK Ltd
BNF category: Respiratory system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 20/04/2018

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, c1-esterase (Berinert®) cannot be endorsed for use within NHS Wales for the prevention of recurrent hereditary angioedema attacks in adolescent and adult patients with C1-esterase inhibitor deficiency.
Statement of Advice (SOA)
Download